RCGP Curriculum - 15.8 Respiratory Problems
This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more
A report from the School of Pharmacy , in London, points to new figures from the WHO showing that 30 per cent of medicines supplied in developing countries are fake.
In eastern European countries the proportion is 10 per cent, while in wealthier areas such as the UK less than 1 per cent of medicines supplied are counterfeits.
But of the 25 new UK cases being investigated by the Medicines and Healthcare products Regulatory, three involve fake treatments being supplied via the legal NHS medicines supply chain.
Professor David Taylor, author of the Trick or Treat report, said: ‘Compared to the harm done by medicines counterfeiting in Africa and Asia, Europe is relatively safe.
‘But there are growing risks which will get worse if, for example, people believe that they cannot get new medicines that may benefit them for conditions such as cancer, dementia or influenza from publicly funded services.’
The School of Pharmacy report calls for stronger legal penalties for medicine counterfeiting, greater freedom of regulated medicines information provision in Europe, and better controls over internet pharmacy and medicines trading.
Quick search - use * for an abbreviated search, eg nico*
This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more
This section of our curriculum guide refers to statement 15.10, Skin Problems, produced by the Royal... Read more
This section of our curriculum guide refers to statement 13, Care of People with Mental Health Probl... Read more
Contributed by Dr Naila Arebi, consultant gastroenterologist, St Mark's Hospital, Harrow, and The Lo... Read more
Contributed by Dr Alan McOwan, lead clinician, Victoria Clinic for HIV and Sexual Health, London. Read more
A non-daily, low oestrogen contraceptive utilising a vaginal delivery system. Read more
Nordic Pharma has launched Siklos (hydroxycarbamide) for the prevention of recurrent painful vaso-oc... Read more
Schering-Plough has launched Bridion (sugammadex) for the reversal of neuromuscular blockade induced... Read more
Comments
Only registered users may comment. Log in now or register for a free account.